Hansoh Pharmaceutical Group Company Limited

SHSC:3692 Stock Report

Market Cap: HK$101.8b

Hansoh Pharmaceutical Group Future Growth

Future criteria checks 1/6

Hansoh Pharmaceutical Group is forecast to grow earnings and revenue by 2.7% and 6.9% per annum respectively. EPS is expected to grow by 2.3% per annum. Return on equity is forecast to be 12.4% in 3 years.

Key information

2.7%

Earnings growth rate

2.3%

EPS growth rate

Pharmaceuticals earnings growth11.2%
Revenue growth rate6.9%
Future return on equity12.4%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SHSC:3692 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202613,8664,4334,3844,22520
12/31/202512,3673,8993,8263,94423
12/31/202412,0564,1493,6793,37223
6/30/202412,0984,7144,1374,653N/A
3/31/202411,1013,9963,4463,885N/A
12/31/202310,1043,2782,7543,116N/A
9/30/20239,7822,9262,2922,615N/A
6/30/20239,4592,5751,8302,114N/A
3/31/20239,4212,5792,1402,427N/A
12/31/20229,3822,5842,4492,741N/A
9/30/20229,6752,6522,6463,004N/A
6/30/20229,9682,7202,8423,267N/A
3/31/20229,9522,7172,4722,922N/A
12/31/20219,9352,7132,1022,577N/A
9/30/20219,5242,6751,4152,345N/A
6/30/20219,1122,6387292,113N/A
3/31/20218,9012,6038402,252N/A
12/31/20208,6902,5699512,390N/A
9/30/20208,3772,5261,7752,802N/A
6/30/20208,0632,4832,6003,213N/A
3/31/20208,3732,5202,6663,271N/A
12/31/20198,6832,5572,7323,330N/A
9/30/20198,6152,3572,5293,092N/A
6/30/20198,5482,1572,3252,854N/A
3/31/20198,1352,0302,0082,463N/A
12/31/20187,7221,9031,6902,072N/A
12/31/20176,1861,595N/A1,402N/A
12/31/20165,4331,476N/A1,247N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 3692's forecast earnings growth (2.7% per year) is above the savings rate (2.3%).

Earnings vs Market: 3692's earnings (2.7% per year) are forecast to grow slower than the Hong Kong market (11.5% per year).

High Growth Earnings: 3692's earnings are forecast to grow, but not significantly.

Revenue vs Market: 3692's revenue (6.9% per year) is forecast to grow slower than the Hong Kong market (7.7% per year).

High Growth Revenue: 3692's revenue (6.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 3692's Return on Equity is forecast to be low in 3 years time (12.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y